Clinical Trial Update: Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients

View source ↗

Summary

An observational secondary-data study evaluating dapagliflozin treatment in adults with chronic kidney disease has completed. The report summarizes treatment pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease (CKD) | Status: COMPLETED